File photo: Doctors Without Borders (MSF) nurse Bhelekazi Mdlalose (L), 51, performs a swab test for COVID-19 coronavirus on a health worker at the Vlakfontein Clinic in Lenasia, Johannesburg, on May 13, 2020. Michele Spatari / AFP
The South African Health Products Regulatory Authority (SAHPRA) has announced that it will be facilitating a controlled, compassionate access programme for the use of the anti-parasitic drug, Ivermectin.
The drug which before now, was not approved for human use in South Africa, has gained popularity recently for its supposed benefits for the treatment of COVID-19.
SAHPRA Chief Executive Officer, Doctor Boitumelo Semete-Makokotlela, however, emphasized that there was not enough scientific evidence to enable a regulator to make a decision on the drug’s use but the programme would be open to all patients, with the healthcare professional being responsible for the application and monitoring of the patient.
Read Also: Gambia Threatens To Name And Shame COVID-19 Rule-Breakers
She also said there is anecdotal evidence of the current, illegal use of the drug on the black market.
Meanwhile, the country is bracing up for the roll-out of a nationwide vaccination programme as the first batch, meant for healthcare workers is expected to leave the Serum Institute in India for South Africa on January 31.
She started playing tennis with her older sister Erika, also now a professional player, in…
With her first-ever major crown, Andreeva also became the first player, man or woman, born…
Left stranded in freezing temperatures near Everest's "death zone", where oxygen levels are critically low,…
The Organization tallied 452 confirmed cases, including 82 deaths, in the Democratic Republic of Congo,…
President Emmanuel Macron paid tribute to Bernadette Chirac as a "great woman of heart" who…
The 77-year-old is leaving his role of 16 years to fight "false allegations" about his…